Literature DB >> 8276804

The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation.

D L Cadena1, C L Chan, G N Gill.   

Abstract

The intracellular portion of the epidermal growth factor receptor consists of a tyrosine kinase domain of approximately 290 amino acids and a COOH-terminal regulatory domain of approximately 230 amino acids that contains five sites of autophosphorylation. The effect of autophosphorylation on the conformation of the intracellular domain has been analyzed using gel filtration. Both phosphorylated and dephosphorylated forms of the intracellular domain exist as monomers and as dimers and appear to have an extended conformation. The Stokes' radii of phosphorylated monomers and dimers were larger than those of the dephosphorylated forms, indicating that the dephosphorylated form is more compact. These results indicate that a significant conformational change occurs in the intracellular portion of the epidermal growth factor receptor upon tyrosine autophosphorylation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8276804

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  A 160-kD systemin receptor on the surface of lycopersicon peruvianum suspension-cultured cells

Authors: 
Journal:  Plant Cell       Date:  1999-08       Impact factor: 11.277

2.  Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands.

Authors:  S Maliartchouk; H U Saragovi
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

3.  Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition.

Authors:  Gloria Salazar; Alfonso González
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

4.  In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition.

Authors:  Noga Kozer; Andrew H A Clayton
Journal:  Eur Biophys J       Date:  2019-11-18       Impact factor: 1.733

5.  Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.

Authors:  Katherine S Yang; Ma Xenia G Ilagan; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

6.  A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  G Goss; H Hirte; W H Miller; I A J Lorimer; D Stewart; G Batist; D A E Parolin; P Hanna; S Stafford; J Friedmann; W Walsh; S Mathews; L Douglas; L K Seymour
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

7.  Physicochemical characterization of the cytoplasmic domain of the epidermal growth factor receptor and evidence for conformational changes associated with its activation by ammonium sulphate.

Authors:  M Gregoriou; P F Jones; J F Timms; J J Yang; S E Radford; A R Rees
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

8.  An investigation of the role of Glu-842, Glu-844 and His-846 in the function of the cytoplasmic domain of the epidermal growth factor receptor.

Authors:  J F Timms; M E Noble; M Gregoriou
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

9.  A region in the cytosolic domain of the epidermal growth factor receptor antithetically regulates the stimulatory and inhibitory guanine nucleotide-binding regulatory proteins of adenylyl cyclase.

Authors:  H Sun; J M Seyer; T B Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

Review 10.  Structure-based view of epidermal growth factor receptor regulation.

Authors:  Kathryn M Ferguson
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.